Chlorhexidine gluconate
Drugs acting on the oropharynx | Ear, Nose and Oropharynx
Items (National)
139.3K
NHS Cost
£420.5K
Practices
6,341
Avg per Practice
22
Overview
Chlorhexidine gluconate is prescribed by 6,341 GP practices across England. In the last 12 months, 139,254 items were prescribed at a total cost of £420,504 to the NHS. It is classified under BNF Chapter Ear, Nose and Oropharynx, Section Drugs acting on the oropharynx.
Monthly Prescribing Trend
Jun 2026
4,524
Jun 2026
4,359
Jun 2026
4,663
Jun 2026
4,450
Jun 2026
4,398
Jun 2026
4,647
Jun 2026
4,378
Jun 2026
4,167
Jun 2026
4,578
Jun 2026
3,991
Jun 2026
4,148
Jun 2026
4,213
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| B | 8,221 | 177 | 46 | +110.9% ▲ |
| E | 5,367 | 112 | 48 | +117.7% ▲ |
| S | 5,008 | 131 | 38 | +73.6% ▲ |
| M | 4,988 | 131 | 38 | +73.2% ▲ |
| L | 4,797 | 115 | 42 | +89.5% ▲ |
| NE | 4,343 | 109 | 40 | +80.9% ▲ |
| N | 4,321 | 93 | 47 | +111.4% ▲ |
| NW | 2,787 | 57 | 49 | +122.3% ▲ |
| SE | 2,670 | 70 | 38 | +73.2% ▲ |
| LE | 2,638 | 83 | 32 | +44.5% ▲ |
| BD | 2,493 | 52 | 48 | +117.7% ▲ |
| LS | 2,483 | 65 | 38 | +73.6% ▲ |
| ST | 2,369 | 65 | 36 | +65.5% ▲ |
| NG | 2,340 | 83 | 28 | +28.2% ▲ |
| PE | 2,051 | 61 | 34 | +52.7% ▲ |
| SW | 2,026 | 57 | 36 | +61.4% ▲ |
| HA | 1,994 | 52 | 38 | +74.1% ▲ |
| SK | 1,753 | 53 | 33 | +50.5% ▲ |
| DN | 1,672 | 51 | 33 | +49.1% ▲ |
| WA | 1,657 | 57 | 29 | +32.3% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| BIRMINGHAM DENTAL HOSPITAL | 411 |
| DRS ADLER AND ROSENBERG | 407 |
| ONE CARE LAMBETH | 342 |
BNF Classification
- Chapter: Ear, Nose and Oropharynx
- Section: Drugs acting on the oropharynx
- Paragraph: Mouth-washes, gargles and dentifrices
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.